Showing results (521-530 of 634) with videos related to
Sort By:
Pageof 64
American Journal of Clinical Oncology|November 1, 2012
A phase II study of bevacizumab, oxaliplatin, and capecitabine in patients with previously untreated metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study GroupYong Sang Hong, Sung Sook Lee, Kyu-pyo Kim, et al.Journal of Experimental & Clinical Cancer Research : CR|July 14, 2021
Immuno-genomic classification of colorectal cancer organoids reveals cancer cells with intrinsic immunogenic properties associated with patient survivalEun Jeong Cho, Minsuh Kim, Daum Jo, et al.Chinese Journal of Cancer|September 13, 2017
Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trialKyung-Hee Lee, Tae Won Kim, Jung-Hun Kang, et al.International Journal of Radiation Oncology, Biology, Physics|May 26, 2005
Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancerJin Cheon Kim, Tae Won Kim, Jong Hoon Kim, et al.Cancer Science|January 10, 2013
Second-line cetuximab/irinotecan versus oxaliplatin/fluoropyrimidines for metastatic colorectal cancer with wild-type KRASYong Sang Hong, Hwa Jung Kim, Seong Joon Park, et al.Plos One|August 13, 2019
Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical centerKyoungmin Lee, So Jung Lee, Shinkyo Yoon, et al.Cancer Research and Treatment|April 7, 2010
Prospective phase II study of preoperative chemoradiation with capecitabine in locally advanced rectal cancerJin-hong Park, Jong Hoon Kim, Seung Do Ahn, et al.International Journal of Radiation Oncology, Biology, Physics|February 4, 2012
Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrenceHo Jung An, Chang Sik Yu, Sung-Cheol Yun, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2019
3'-Deoxy-3'-<sup>18</sup>F-Fluorothymidine and <sup>18</sup>F-Fluorodeoxyglucose positron emission tomography for the early prediction of response to Regorafenib in patients with metastatic colorectal cancer refractory to all standard therapiesJeong Eun Kim, Sun Young Chae, Jwa Hoon Kim, et al.Oncology|January 23, 2009
Efficacy and safety of S-1 monotherapy in patients with advanced biliary tract adenocarcinoma: retrospective analysis of 162 patientsInkeun Park, Jae-Lyun Lee, Min-Hee Ryu, et al.Pageof 64